Skip to main content
. 2014 Aug 14;9(8):e105097. doi: 10.1371/journal.pone.0105097

Table 4. Top annotated transcripts differentially expressed in resistant oysters at early time points after challenge with R. crassostreae (GX 1 and 5 days).

Contig logFC_1d logFC_5d Annotation Accession #
comp1506_c0_seq4 2.71 3.08 ADAMTS8 XP_002940685
comp4626_c0_seq4 3.34 - alpha-ketoglutarate-dependent hypophosphite dioxygenase-like XP_002944900
comp1285_c1_seq8 - −3.90 arginase type-i-like, arginase-i AEB70965
comp1285_c1_seq3 - −3.54 arginase type-i-like, arginase-i XP_002130834
comp5608_c0_seq1 - −6.92 c-type lectin ABB71672
comp24124_c0_seq1 - 4.49 ched related family member (ptr-19) XP_002734100
comp5722_c1_seq1,2 - −3.35 collagen alpha XP_001512734
comp7972_c0_seq1 - −8.09 cubilin XP_002734392
comp7972_c0_seq4 - −3.11 cubilin XP_002612977
comp1788_c0_seq4 - 3.26 fibrinolytic enzyme CAA64472
comp18756_c0_seq3 3.48 fibropellin ia XP_002601363
comp6161_c0_seq11 - 2.48 furin AAA49718
comp810_c1_seq1 - −3.40 heat shock protein 22 ACU83231
comp18757_c0_seq1 - −7.14 hla-b associated transcript 1 XP_003217350
comp2015_c0_seq13 −7.19 - inhibitor of apoptosis (IAP) AEB54799
comp2015_c0_seq24 3.95 - inhibitor of apoptosis (IAP) AEB54800
comp15440_c0_seq1 3.18 - inhibitor of apoptosis (IAP) XP_002426441
comp6837_c0_seq1 3.02 - interleukin 17 A9XE49
comp3858_c0_seq5 3.63 - isoleucyl-trna synthetase NP_001090690
comp5396_c0_seq1 - −3.01 melatonin receptor 1a ADM73175
comp7137_c0_seq2 - 3.26 organic solute transporter subunit alpha XP_002732822
comp39520_c0_seq1 - −4.31 polyprotein XP_002740782
comp24428_c0_seq1 −8.68 −8.64 rapunzel 5 NP_001103594
comp18902_c0_seq1 - −3.43 rho gtpase XP_002739105
comp1023_c0_seq2 - 2.62 scavenger receptor cysteine-rich ACT53266
comp1023_c0_seq3 3.07 2.93 scavenger receptor cysteine-rich XP_001622238
comp18756_c0_seq2 3.83 - sushi repeat-containing XP_002664481
comp25746_c0_seq4 - −7.60 tenascin xb XP_002741293
comp6161_c0_seq5 3.49 - type 2 proinsulin processing endopeptidase 2206277A

Magnitude of differential expression in each treatment group is expressed as log10 fold change (logFC) over expression in the control group (CGX15/30d). The name and accession number for the best BLASTx hits are shown.